Your browser doesn't support javascript.
loading
Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy.
Yokoi, Mari; Tsuji, Daiki; Suzuki, Kenichi; Kawasaki, Yohei; Nakao, Masahiko; Ayuhara, Hideaki; Kogure, Yuuki; Shibata, Kazuhiko; Hayashi, Toshinobu; Hirai, Keita; Inoue, Kazuyuki; Hama, Toshihiro; Takeda, Koji; Nishio, Makoto; Itoh, Kunihiko.
Afiliação
  • Yokoi M; Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-ku, Shizuoka, Shizuoka, 422-8002, Japan.
  • Tsuji D; Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-ku, Shizuoka, Shizuoka, 422-8002, Japan. d-tsuji@u-shizuoka-ken.ac.jp.
  • Suzuki K; Department of Pharmacy, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan.
  • Kawasaki Y; Department of Drug Evaluation and Informatics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
  • Nakao M; Department of Pharmacy, Osaka City General Hospital, Osaka, Japan.
  • Ayuhara H; Department of Pharmacy, Tokyo Medical University Hospital, Tokyo, Japan.
  • Kogure Y; Department of Pharmacy, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
  • Shibata K; Department of Medical Oncology, Kouseiren Takaoka Hospital, Takaoka, Japan.
  • Hayashi T; Department of Pharmacy, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Hirai K; Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-ku, Shizuoka, Shizuoka, 422-8002, Japan.
  • Inoue K; Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-ku, Shizuoka, Shizuoka, 422-8002, Japan.
  • Hama T; Department of Pharmacy, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan.
  • Takeda K; Department of Clinical Oncology, Osaka City General Hospital, Osaka, Japan.
  • Nishio M; Department of Thoracic Medical Oncology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan.
  • Itoh K; Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-ku, Shizuoka, Shizuoka, 422-8002, Japan.
Support Care Cancer ; 26(5): 1505-1513, 2018 May.
Article em En | MEDLINE | ID: mdl-29177570
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vômito / Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Náusea / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vômito / Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Náusea / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão